ABT-263, 25 mg

Supplied by STEMCELL Technologies, this laboratory chemical is a B cell lymphoma 2 (Bcl-2) family inhibitor, also known by the synonym Navitoclax. The substance is identified by the chemical name 4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]-phenyl]sulfonyl]-benzamide and carries CAS number 923564-51-6.

The product is a white solid presented as a powder. Its molecular formula is C47H55ClF3N5O6S3 with a molecular weight of 974.6. According to the manufacturer's Safety Data Sheet, it is soluble in DMSO at 25 mg/mL and is not flammable under standard conditions.

The chemical is not classified as hazardous under the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200). It is reported to be stable under recommended transport and storage conditions and should be kept away from strong oxidizing agents. The product is not regulated for transport by DOT, TDG, MEX, ICAO, IATA, IMDG, RID, ADR, or ADN. The RTECS number is CV2467355.